Explore
Validate
Learn
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN358164 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Met Proto-Oncogene (MET) (pTyr1349) antibody
- Antibody type
- Polyclonal
- Description
- Protein G affinity chromatography. Then, the antibody fraction is peptide affinity purified in a 2-step procedure with control and phosphorylated peptides. The phospho-specific antibody is eluted with high and low pH buffers and neutralized immediately, followed by dialysis against PBS.
- Reactivity
- Human
- Host
- Rabbit
- Epitope
- pTyr1349
- Vial size
- 0.4 mL
- Storage
- Store the antibody undiluted at 2-8°C for one month or (in aliquots) at-20°C for longer.
- Handling
- Avoid repeated freezing and thawing.
Submitted references MUC20 suppresses the hepatocyte growth factor-induced Grb2-Ras pathway by binding to a multifunctional docking site of met.
Activation of the hepatocyte growth factor (HGF)-Met system in papillary thyroid cancer: biological effects of HGF in thyroid cancer cells depend on Met expression levels.
Progressive changes in Met-dependent signaling in a human ovarian surface epithelial model of malignant transformation.
Reactive oxygen species mediate Met receptor transactivation by G protein-coupled receptors and the epidermal growth factor receptor in human carcinoma cells.
The Met receptor and alpha 6 beta 4 integrin can function independently to promote carcinoma invasion.
Higuchi T, Orita T, Katsuya K, Yamasaki Y, Akiyama K, Li H, Yamamoto T, Saito Y, Nakamura M
Molecular and cellular biology 2004 Sep;24(17):7456-68
Molecular and cellular biology 2004 Sep;24(17):7456-68
Activation of the hepatocyte growth factor (HGF)-Met system in papillary thyroid cancer: biological effects of HGF in thyroid cancer cells depend on Met expression levels.
Mineo R, Costantino A, Frasca F, Sciacca L, Russo S, Vigneri R, Belfiore A
Endocrinology 2004 Sep;145(9):4355-65
Endocrinology 2004 Sep;145(9):4355-65
Progressive changes in Met-dependent signaling in a human ovarian surface epithelial model of malignant transformation.
Wong AS, Roskelley CD, Pelech S, Miller D, Leung PC, Auersperg N
Experimental cell research 2004 Sep 10;299(1):248-56
Experimental cell research 2004 Sep 10;299(1):248-56
Reactive oxygen species mediate Met receptor transactivation by G protein-coupled receptors and the epidermal growth factor receptor in human carcinoma cells.
Fischer OM, Giordano S, Comoglio PM, Ullrich A
The Journal of biological chemistry 2004 Jul 9;279(28):28970-8
The Journal of biological chemistry 2004 Jul 9;279(28):28970-8
The Met receptor and alpha 6 beta 4 integrin can function independently to promote carcinoma invasion.
Chung J, Yoon SO, Lipscomb EA, Mercurio AM
The Journal of biological chemistry 2004 Jul 30;279(31):32287-93
The Journal of biological chemistry 2004 Jul 30;279(31):32287-93
No comments: Submit comment
No validations: Submit validation data